Manufacturer of Controlled Substances; Notice of Application, 36730-36731 [E7-12971]
Download as PDF
<![CDATA[
36730
Federal Register / Vol. 72, No. 128 / Thursday, July 5, 2007 / Notices
Drug
Schedule
Methadone (9250) ........................
Dextropropoxyphene, bulk, (9273)
Morphine (9300) ...........................
II
II
II
The company plans to manufacture
the listed controlled substances as bulk
reagents for use in drug abuse testing.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), Washington, DC 20537, or any
being sent via express mail should be
sent to Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 2401 Jefferson Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than September 4, 2007.
Dated: June 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–12973 Filed 7–3–07; 8:45 am]
The company plans to manufacture
the listed controlled substances in bulk
for conversion and sale to dosage form
manufacturers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), Washington, DC 20537, or any
being sent via express mail should be
sent to Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 2401 Jefferson Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than September 4, 2007.
Dated: June 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–12974 Filed 7–3–07; 8:45 am]
DEPARTMENT OF JUSTICE
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on February 14, 2007,
Rhodes Technologies, 498 Washington
Street, Coventry, Rhode Island 02816,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in schedule
I and II:
sroberts on PROD1PC70 with NOTICES
Drug
Schedule
Tetrahydrocannabinols (7370) .....
Methylphenidate (1724) ................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Fentanyl (9801) ............................
VerDate Aug<31>2005
18:43 Jul 03, 2007
I
II
II
II
II
II
II
II
II
II
II
Jkt 211001
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Dated: June 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–12975 Filed 7–3–07; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
Drug Enforcement Administration
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), Washington, DC 20537, or any
being sent via express mail should be
sent to Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 2401 Jefferson Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than September 4, 2007.
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on April 9, 2007,
Siegfried (USA), Inc., Industrial Park
Road, Pennsville, New Jersey 08070,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in schedule
I and II:
Drug
Frm 00084
Fmt 4703
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on March 29, 2007,
Sigma Aldrich Research Biochemicals,
Inc., 1–3 Strathmore Road, Natick,
Massachusetts 01760, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedule I and II:
Drug
Schedule
Dihydromorphine (9145) ...............
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Oxymorphone (9652) ...................
PO 00000
Drug Enforcement Administration
Sfmt 4703
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Cathinone (1235) ..........................
Methcathinone (1237) ..................
Aminorex (1585) ...........................
Alpha-ethyltryptamine (7249) .......
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) .....
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
E:\FR\FM\05JYN1.SGM
05JYN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
Federal Register / Vol. 72, No. 128 / Thursday, July 5, 2007 / Notices
Schedule
Drug
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4-Methylenedioxy methamphetamine (MDMA) (7405).
1-[1-(2Thienyl)cyclohexyl]piperidine
(TCP) (7470).
1-Benzylpiperazine (BZP) (7493)
Heroin (9200) ...............................
Normorphine (9313) .....................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Nabilone (7379) ............................
1–Phenylcyclohexylamine (7460)
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Codeine (9050) .............................
Diprenorphine (9058) ...................
Ecgonine (9180) ...........................
Levomethorphan (9210) ...............
Levorphanol (9220) ......................
Meperidine (9230) ........................
Metazocine (9240) ........................
Methadone (9250) ........................
Morphine (9300) ...........................
Thebaine (9333) ...........................
Levo-alphacetylmethadol (9648) ..
Carfentanil (9743) .........................
Fentanyl (9801) ............................
Employment and Training
Administration
I
[TA–W–61,298]
I
American Manufacturing International,
Inc. Patterson, NJ; Notice of Negative
Determination Regarding Application
for Reconsideration; Correction
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
ACTION:
Correction
sroberts on PROD1PC70 with NOTICES
Dated: June 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–12971 Filed 7–3–07; 8:45 am]
BILLING CODE 4410–09–P
18:43 Jul 03, 2007
Jkt 211001
Notice; correction.
SUMMARY: The Department of Labor,
Employment and Training
Administration published a document
in the Federal Register on May 30,
2007, concerning a Notice of Negative
Determination Regarding Application
for Reconsideration. The office
restructured a paragraph for clarification
purposes.
The company plans to manufacture
reference standards.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), Washington, DC 20537, or any
being sent via express mail should be
sent to Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 2401 Jefferson Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than September 4, 2007.
VerDate Aug<31>2005
Correction.
In the Federal Register of June 14,
2007, in FR Doc. E7–11479, on page
32914, in the third column, correct the
‘‘text’’ caption to read:
DEPARTMENT OF LABOR
I
36731
In the Federal Register of May 30,
2007, in FR Doc. E7–10310, on page
30029, in the first and second column,
correct the ‘‘text’’ caption to read:
Since the total number of separated
workers was one during the relevant
period, workers of American
Manufacturing International, Inc.,
Patterson, New Jersey do not meet the
group eligibility requirements for trade
adjustment assistance.
Signed in Washington, DC, this 27th day of
June 2007.
Elliott S. Kushner,
Certifying Officer, Division of Trade
Adjustment Assistance.
[FR Doc. E7–12914 Filed 7–3–07; 8:45 am]
BILLING CODE 4510–FN–P
All workers of Armstrong Wood Products,
Inc., Armstrong Hardwood Flooring
Company, Parquet Flooring Department,
Oneida, Tennessee [TA–W–60,876], who
became totally or partially separated from
employment on or after March 17, 2007
through two years from the date of this
certification, are eligible to apply for
adjustment assistance under Section 223 of
the Trade Act of 1974, are also eligible to
apply for alternative trade adjustment
assistance under Section 246 of the Trade Act
of 1974.
and
All workers of Armstrong Wood Products,
Inc., Armstrong Hardwood Flooring
Company, Pattern Plus Flooring Department,
Oneida, Tennessee [TA–W–60,876B], who
became totally or partially separated from
employment on or after January 31, 2006
through two years from the date of this
certification, are eligible to apply for
adjustment assistance under Section 223 of
the Trade Act of 1974, and are also eligible
to apply for alternative trade adjustment
assistance under Section 246 of the Trade Act
of 1974.
Signed in Washington DC this 27th day of
June 2007.
Elliott S. Kushner,
Certifying Officer, Division of Trade
Adjustment Assistance.
[FR Doc. E7–12911 Filed 7–3–07; 8:45 am]
BILLING CODE 4510–FN–P
DEPARTMENT OF LABOR
Employment and Training
Administration
[TA–W–61,281]
DEPARTMENT OF LABOR
Form Tech Industries, LLC, Canal
Fulton, OH; Notice of Affirmative
Determination Regarding Application
for Reconsideration
Employment and Training
Administration
[TA–W–60,876 and TA–W–60,876B]
Armstrong Wood Products, Inc.,
Armstrong Hardwood Flooring
Company, Parquet Flooring
Department and Pattern Plus Flooring
Department, Oneida, TN; Notice of
Revised Determination on
Reconsideration; Correction
ACTION:
Notice; correction.
SUMMARY: The Department of Labor,
Employment and Training
Administration published a document
in the Federal Register on June 14,
2007, concerning a Notice of Revised
Determination on Reconsideration. The
document contained an incorrect date.
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
By application dated June 12, 2007,
the United Automobile, Aerospace &
Agricultural Implement Workers of
America, Local 1112 requested
administrative reconsideration of the
Department of Labor’s Notice of
Negative Determination Regarding
Eligibility to Apply for Worker
Adjustment Assistance, applicable to
workers and former workers of the
subject firm. The determination was
signed on May 9, 2007 and published in
the Federal Register on May 24, 2007
(72 FR 29182).
The initial investigation resulted in a
negative determination based on the
finding that imports of machine parts,
such as shafts and sheaves for CVT
E:\FR\FM\05JYN1.SGM
05JYN1
]]>Agencies
[Federal Register Volume 72, Number 128 (Thursday, July 5, 2007)]
[Notices]
[Pages 36730-36731]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-12971]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on March 29, 2007, Sigma Aldrich
Research Biochemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts
01760, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in schedule I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
Methcathinone (1237)....................... I
Aminorex (1585)............................ I
Alpha-ethyltryptamine (7249)............... I
Lysergic acid diethylamide (7315).......... I
Tetrahydrocannabinols (7370)............... I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
2,5-Dimethoxyamphetamine (7396)............ I
3,4-Methylenedioxyamphetamine (7400)....... I
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
[[Page 36731]]
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxy methamphetamine (MDMA) I
(7405).
1-[1-(2-Thienyl)cyclohexyl]piperidine (TCP) I
(7470).
1-Benzylpiperazine (BZP) (7493)............ I
Heroin (9200).............................. I
Normorphine (9313)......................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Nabilone (7379)............................ II
1-Phenylcyclohexylamine (7460)............. II
Phencyclidine (7471)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Diprenorphine (9058)....................... II
Ecgonine (9180)............................ II
Levomethorphan (9210)...................... II
Levorphanol (9220)......................... II
Meperidine (9230).......................... II
Metazocine (9240).......................... II
Methadone (9250)........................... II
Morphine (9300)............................ II
Thebaine (9333)............................ II
Levo-alphacetylmethadol (9648)............. II
Carfentanil (9743)......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture reference standards.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Drug Enforcement
Administration, Office of Diversion Control, Federal Register
Representative (ODL), Washington, DC 20537, or any being sent via
express mail should be sent to Drug Enforcement Administration, Office
of Diversion Control, Federal Register Representative (ODL), 2401
Jefferson Davis Highway, Alexandria, Virginia 22301; and must be filed
no later than September 4, 2007.
Dated: June 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-12971 Filed 7-3-07; 8:45 am]
BILLING CODE 4410-09-P
